Alzheimer's Disease


Up to $1800


Alzheimer’s Disease with Gum Disease

Official Title

Alzheimer's Disease

Study Summary

The study is a randomized, double-blind, placebo-controlled, multiple ascending dose study to assess the safety and tolerability of ascending repeat doses of COR388 HCl in older healthy male and female subjects and a cohort of Alzheimer's disease subjects.

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 55-80
Inclusion call for more information
Exclusion History or current evidence of clinically significant arrhythmia, heart failure, or hypotension
Start Date
Compensation Up to $1800
Location Orlando, FL

Study Information

Condition Alzheimer's Disease

Administrative Information

Study ID NCT03418688

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.